Epic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is an open question.
No one sure is why long Covid occurs. That absence of certainty leaves plenty of room for competing theories to sprout up.
Researchers at Harvard reported findings last week in a preprint posted on medRxiv suggesting that people with long Covid may harbor a reservoir of active SARS-CoV-2 virus, possibly in the gastrointestinal tract, long after the acute illness is over. A different group of Harvard researchers drew a causal line between long COVID and tiny blood clots and are testing whether blood thinners might be an effective treatment. And there is a group at the University of California, San Francisco, who linked long COVID to reactivated Epstein-Barr virus, also in a medRxiv preprint.
Researchers at Epic, the electronic health record company, have added another subplot to this complicated tale of lingering disease. Using an Epic data set dubbed Cosmos that includes 142 million patients, they found that there is a notable number of cases of “long flu” and “long viral pneumonia” when, just as with long Covid, people experience a variety of symptoms after the acute respiratory illness is over.
“This something I had never thought about as a physician,” says Jeff Trinkl, M.D., director of clinical informatics at Epic. “I didn’t think about long-term illness — that two months later (patients) may have brain fog or may be having this fatigue. I never made that association.”
The Epic findings, which the company published on the Epic Research website earlier this month but have not been reported in a peer-reviewed journal, found that “long flu” and “long viral pneumonia” may be more common than long Covid.
Related: No Giving It Short Shrift: COVID-19 Can Be a Long Haul
According to Trinkl and his colleagues, 17.6% of patients hospitalized for flu had new symptoms after their acute illness compared with 15.5% of those hospitalized for other viral pneumonias and 13.9% of those hospitalized for COVID-19. The symptoms included in their study included fatigue, loss of smell or taste, heart palpitations, chest pain, difficulty breathing, myalgia (muscle pain) and brain fog. The research focused on symptoms for which patients sought care starting 28 days after the acute illness was over and during the following five months (in other words, between 28 and 180 days after the acute illness was over).
Once the researchers factored in a baseline rate of symptoms (calculated by looking at the symptom complaints before the acute illness) the percentage of patients who might be classified as having long flu was smaller — 6.4% — but still larger than the 5.2% who had symptoms that might be grouped under the heading long Covid.
The Epic researchers also looked at patients seeking care for new symptoms after a bout of acute viral respiratory illness that did not result in hospitalization and, therefore, presumably had a milder acute episode. In that group, the proportion of long viral pneumonia cases was higher than the long Covid and long flu cases (11.1%, 8.7% and 5.9%, respectively).
The COVID-19 patients in the study were diagnosed between Jan. 1, 2020, and July 1, 2021. The flu and other viral pneumonia cases were diagnosed before the COVID-19 pandemic, between Jan. 1, 2018, and July 1, 2019.
Long Covid has put a spotlight on the after-effects of viral illness, comments Trinkl. “In 2018,” Trinkl says, “[if] you ended up having some of the symptoms that we looked at — tiredness, fatigue — and some of them are a little bit more specific, like chest pain — you may not look back and say, ‘Oh, this is tied to this viral infection I had quite a while back.’ You may not even go in for it because you would have said, ‘I’m just tired,'” says Trinkl.
“But now COVID comes,” Trinkl continues, “and there's so much discussion about some of the symptoms you can have in a long-term fashion, so I feel like the population for the COVID is more sensitized to looking for these types of symptoms.”
It is certainly possible (indeed, likely probable) that because of long Covid, and findings such as these, more people will seek care for long-term symptoms after flu and other respiratory illnesses.
Trinkl and his colleagues want their results to lead to more research. “It’s something that deserves to be a broader conversation, because we do see this pattern repeated across infections,” says Eric Barkley, an Epic data scientist and one of the researchers involved in this Epic research.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More